It has taken Medtronic (NYSE: MDT) a considerable amount of time to regain momentum, but it has, and its stock price is on ...

Medtronic stock recently received an RS Rating upgrade from 67 to 82 making it a great stock to consider for a bullish option ...

Medtronic PLC’s stock reached a 52-week high, climbing to 105.25 USD, marking a significant milestone for the company. This peak reflects a robust performance over the past year, during which the ...

Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients around the globe. With a market ...

Medtronic stock has recently seen its fair value price target raised to $109.82 per share, up from $101.13. This change reflects improved analyst sentiment. The upward revision, combined with a ...

Medtronic raised its fiscal year 2026 organic revenue growth guidance to 5.5% from 5%. The medical devices giant raised ...

Medical device manufacturer Medtronic (NYSE: MDT) is a healthcare industry stalwart. The company, based in the U.S. and Ireland, is one of the largest in its segment, developing and selling a diverse ...

Analysts expect the Galway, Ireland-based company to report quarterly earnings of $1.31 per share, up from $1.26 per share in ...

Medtronic (MDT) stock is upgraded to Neutral from Sell at Goldman Sachs after the firm recorded strong Q2 FY26 results and ...

Medtronic plc (NYSE:MDT – Get Free Report) shares were up 0.3% on Thursday after UBS Group raised their price target on the stock from $85.00 to $95.00. UBS Group currently has a neutral rating on the ...